- Report
- October 2023
Ireland
From €882EUR$950USD£736GBP
From €882EUR$950USD£736GBP
From €882EUR$950USD£736GBP
- Report
- October 2023
Czech Republic
From €882EUR$950USD£736GBP
- Report
- October 2023
Saudi Arabia
From €882EUR$950USD£736GBP
- Report
- October 2023
El Salvador
From €882EUR$950USD£736GBP
- Report
- October 2023
Netherlands
From €882EUR$950USD£736GBP
- Report
- October 2023
New Zealand
From €882EUR$950USD£736GBP
- Report
- October 2023
Philippines
From €882EUR$950USD£736GBP
From €882EUR$950USD£736GBP
- Report
- October 2023
South Korea
From €882EUR$950USD£736GBP
- Report
- October 2023
Switzerland
From €882EUR$950USD£736GBP
- Report
- October 2023
Bangladesh
From €882EUR$950USD£736GBP
- Report
- October 2023
Costa Rica
From €882EUR$950USD£736GBP
- Report
- October 2023
Kazakhstan
From €882EUR$950USD£736GBP
- Report
- October 2023
Argentina
From €882EUR$950USD£736GBP
- Report
- October 2023
Australia
From €882EUR$950USD£736GBP
- Report
- October 2023
Guatemala
From €882EUR$950USD£736GBP
- Report
- October 2023
Hong Kong
From €882EUR$950USD£736GBP
- Report
- October 2023
Indonesia
From €882EUR$950USD£736GBP

The Immunodiagnostic market is a segment of the In Vitro Diagnostics (IVD) industry. It is focused on the development and production of tests that use antibodies to detect the presence of a specific antigen in a sample. These tests are used to diagnose a wide range of diseases, including cancer, autoimmune disorders, and infectious diseases. Immunodiagnostics are also used to monitor the effectiveness of treatments and to assess the risk of developing certain diseases.
Immunodiagnostics are typically performed in a laboratory setting, using a variety of techniques such as enzyme-linked immunosorbent assays (ELISA), immunofluorescence, and immunohistochemistry. These tests are often used in combination with other diagnostic methods, such as imaging and molecular diagnostics, to provide a more comprehensive diagnosis.
Some of the major companies in the Immunodiagnostic market include Abbott Laboratories, Becton Dickinson, Roche Diagnostics, Siemens Healthineers, and Thermo Fisher Scientific. Show Less Read more